Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis.

Pharmacoecon Open · 2022 · PMC9283622 · PMID 35733076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

With this in mind, although the PREDNOS2 trial showed that the difference in SSNS relapse between the treatment arms did not reach statistical significance, there was a difference in relapse rate favouring the prednisolone arm.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.